Proteon Therapeutics Announces First Quarter 2019 Financial Results
May 08, 2019 08:00 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., May 08, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
Nephros to Present at Taglich Brothers 16th Annual Investment Conference on April 30, 2019 in New York City
April 24, 2019 07:30 ET
|
Nephros, Inc.
SOUTH ORANGE, NJ, April 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc.(OTCQB: NEPH), a commercial stage company that develops and sells high performance liquid purification filters...
Proteon Therapeutics Announces Review of Potential Strategic Transactions
April 15, 2019 16:30 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., April 15, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
Proteon Therapeutics Announces Top-Line Results From Phase 3 PATENCY-2 Clinical Trial of Vonapanitase in Radiocephalic Arteriovenous Fistulas
March 28, 2019 08:00 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., March 28, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
LogistiCare Raises Public Awareness during National Kidney Month
March 19, 2019 11:45 ET
|
LogistiCare
ATLANTA, March 19, 2019 (GLOBE NEWSWIRE) -- In the United States, more than 661,000 people suffer from kidney failure. Of these, 468,000 individuals are on dialysis, and roughly 193,000 live with a...
Proteon Therapeutics Announces Fourth Quarter and Full-Year 2018 Financial Results
March 13, 2019 08:00 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., March 13, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
Nephros Reports 2018 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
March 12, 2019 07:45 ET
|
Nephros, Inc.
Annual Product Revenues Up 54% SOUTH ORANGE, N.J., March 12, 2019 (GLOBE NEWSWIRE) -- Nephros, Inc. (OTCQB:NEPH), a commercial stage company that develops and sells high performance liquid...
Proteon Therapeutics to Present at the Cowen and Company 39th Annual Health Care Conference on March 11th
March 04, 2019 16:30 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., March 04, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq: PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Robert I. Schattner Foundation provides $150,000 grant to American Kidney Fund for children’s programs and financial assistance to dialysis patients in D.C. region
January 30, 2019 13:15 ET
|
American Kidney Fund
ROCKVILLE, Md., Jan. 30, 2019 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today announced a $150,000 grant from the Robert I. Schattner Foundation to help fund three programs—two that support...
Proteon Therapeutics Announces Publication of Results from Phase 3 PATENCY-1 Clinical Trial of Investigational Vonapanitase in Patients with Chronic Kidney Disease
January 24, 2019 08:00 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...